Ann Hynes
Stock Analyst at Mizuho Securities
(4.80)
# 528
Out of 5,078 analysts
1144
Total ratings
62.6%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Reiterated: Buy | $470 → $490 | $439.95 | +11.38% | 47 | Oct 23, 2026 | |
| MEDP Medpace Holdings | Reiterated: Buy | $700 → $730 | $669.20 | +9.09% | 16 | Oct 23, 2026 | |
| UNH UnitedHealth Group | Reiterated: Buy | $493 → $500 | $418.09 | +19.59% | 58 | Oct 22, 2026 | |
| HUM Humana | Reiterated: Buy | $468 → $495 | $422.07 | +17.28% | 48 | Oct 13, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $275 → $300 | $279.36 | +7.39% | 54 | Oct 7, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Hold | $264 → $295 | $345.37 | -14.58% | 16 | Sep 25, 2026 | |
| EHC Encompass Health | Reiterated: Buy | $134 → $140 | $124.09 | +12.82% | 42 | Aug 11, 2026 | |
| MD Pediatrix Medical Group | Reiterated: Hold | $27 → $28 | $29.29 | -4.40% | 46 | Aug 11, 2026 | |
| CON Concentra Group Holdings Parent | Reiterated: Buy | $35 → $40 | $39.25 | +1.91% | 11 | Aug 10, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | $320 → $355 | $328.95 | +7.92% | 62 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $290 | $268.45 | +8.03% | 54 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $13 | $12.27 | +5.95% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 | $60.11 | +43.07% | 21 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $19 | $23.63 | -19.59% | 16 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 | $241.89 | +7.49% | 65 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 → $475 | $469.03 | +1.27% | 64 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $27 → $31 | $31.51 | -1.62% | 46 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $63 → $69 | $70.17 | -1.67% | 38 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $120 | $93.47 | +28.38% | 74 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 → $255 | $209.15 | +21.92% | 36 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $15.75 | +20.63% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $200 | $186.89 | +7.01% | 62 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $190 | $185.27 | +2.55% | 53 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $330 → $340 | $306.95 | +10.77% | 38 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $331.00 | n/a | 38 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1,000.77 | n/a | 52 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 | $249.57 | n/a | 43 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $220 | $136.29 | n/a | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $623.60 | n/a | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $69.58 | n/a | 1 | Apr 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.6 | $2.92 | n/a | 16 | Jul 27, 2018 |
Elevance Health
Oct 23, 2026
Reiterated: Buy
Price Target: $470 → $490
Current: $439.95
Upside: +11.38%
Medpace Holdings
Oct 23, 2026
Reiterated: Buy
Price Target: $700 → $730
Current: $669.20
Upside: +9.09%
UnitedHealth Group
Oct 22, 2026
Reiterated: Buy
Price Target: $493 → $500
Current: $418.09
Upside: +19.59%
Humana
Oct 13, 2026
Reiterated: Buy
Price Target: $468 → $495
Current: $422.07
Upside: +17.28%
IQVIA Holdings
Oct 7, 2026
Reiterated: Buy
Price Target: $275 → $300
Current: $279.36
Upside: +7.39%
Charles River Laboratories International
Sep 25, 2026
Reiterated: Hold
Price Target: $264 → $295
Current: $345.37
Upside: -14.58%
Encompass Health
Aug 11, 2026
Reiterated: Buy
Price Target: $134 → $140
Current: $124.09
Upside: +12.82%
Pediatrix Medical Group
Aug 11, 2026
Reiterated: Hold
Price Target: $27 → $28
Current: $29.29
Upside: -4.40%
Concentra Group Holdings Parent
Aug 10, 2026
Reiterated: Buy
Price Target: $35 → $40
Current: $39.25
Upside: +1.91%
Labcorp Holdings
Aug 10, 2026
Reiterated: Buy
Price Target: $320 → $355
Current: $328.95
Upside: +7.92%
Aug 10, 2026
Reiterated: Buy
Price Target: $250 → $290
Current: $268.45
Upside: +8.03%
Aug 6, 2026
Reiterated: Buy
Price Target: $12 → $13
Current: $12.27
Upside: +5.95%
Jul 31, 2026
Reiterated: Buy
Price Target: $86
Current: $60.11
Upside: +43.07%
Jul 31, 2026
Reiterated: Hold
Price Target: $16 → $19
Current: $23.63
Upside: -19.59%
Jul 28, 2026
Reiterated: Buy
Price Target: $260
Current: $241.89
Upside: +7.49%
Jul 28, 2026
Reiterated: Buy
Price Target: $525 → $475
Current: $469.03
Upside: +1.27%
Jul 13, 2026
Reiterated: Hold
Price Target: $27 → $31
Current: $31.51
Upside: -1.62%
Jul 13, 2026
Reiterated: Hold
Price Target: $63 → $69
Current: $70.17
Upside: -1.67%
Jul 13, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $93.47
Upside: +28.38%
Jul 13, 2026
Reiterated: Buy
Price Target: $215 → $255
Current: $209.15
Upside: +21.92%
Jul 13, 2026
Reiterated: Buy
Price Target: $17 → $19
Current: $15.75
Upside: +20.63%
Jul 13, 2026
Reiterated: Buy
Price Target: $230 → $200
Current: $186.89
Upside: +7.01%
Jun 26, 2026
Reiterated: Buy
Price Target: $180 → $190
Current: $185.27
Upside: +2.55%
Jun 8, 2026
Reiterated: Buy
Price Target: $330 → $340
Current: $306.95
Upside: +10.77%
Mar 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $331.00
Upside: n/a
Nov 6, 2024
Reiterated: Hold
Price Target: n/a
Current: $1,000.77
Upside: n/a
Nov 4, 2024
Rated: Hold
Price Target: $110
Current: $249.57
Upside: n/a
Nov 8, 2022
Reiterated: Hold
Price Target: $220
Current: $136.29
Upside: n/a
Sep 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $623.60
Upside: n/a
Apr 11, 2022
Reiterated: Buy
Price Target: n/a
Current: $69.58
Upside: n/a
Jul 27, 2018
Reiterated: Hold
Price Target: $4.5 → $3.6
Current: $2.92
Upside: n/a